Ligand · BKI
BKI · 5-(4-bromophenyl)-7-phenyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
BKI, 5-(4-bromophenyl)-7-phenyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one (C18 H12 Br N3 O, 366.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- BKI
- Formula
- C18 H12 Br N3 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BKI in 2 structures; the first of them:
- 4D4J · human PFKFB3 in complex with a pyrrolopyrimidone compound · BKI A1449 · binds ALA44, ARG45, GLY46, TYR49, ILE50, SER152, VAL159, ASN163 and 10 more
- 4D4J · Human PFKFB3 in complex with a pyrrolopyrimidone compound · BKI A1449 · binds ALA44, ARG45, GLY46, TYR49, ILE50, SER152, VAL159, ASN163 and 10 more
Residues it binds most
VAL 2, ALA 2, GLY 2, ILE 2, ARG 2, ASN 2, GLU 2, LEU 2, PHE 2, SER 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.